Hepatitis c treatment concomitant to chemotherapy as "salvage" therapy in children with hematologic malignanciES

Pediatric Infectious Disease Journal

Volumn 29, Issue 3, 2010, Pages 277-280

  Papaevangelou, Vassiliki ^a   Varsami, Marianna ^b   Papadakis, Vassilios ^b   Zellos, Aglaia ^a   Parcharidou, Agapi ^b   Papargyri, Sophia ^b   Karentzou, Ourania ^b   Manolaki, Nina ^b   Roma, Eleftheria ^a   Polychronopoulou, Sophia ^b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

Author keywords

Antiviral treatment; Chemotherapy; Children; Chronic hepatitis C; Leukemia; Lymphoma

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; AMINOTRANSFERASE; ANTINEOPLASTIC AGENT; BILIRUBIN; HEPATITIS C ANTIBODY; VIRUS RNA;

ACUTE LYMPHOCYTIC LEUKEMIA; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; ANOREXIA; ANTIBODY DETECTION; ANTIVIRAL THERAPY; ARTICLE; B CELL LYMPHOMA; BLOOD CLOTTING DISORDER; CACHEXIA; CANCER CHEMOTHERAPY; CANCER REGRESSION; CANCER RELAPSE; CASE REPORT; CHILD; CHILDHOOD CANCER; DEPRESSION; DISEASE EXACERBATION; DRUG WITHDRAWAL; FATIGUE; FEBRILE NEUTROPENIA; GENOTYPE; HEPATITIS C; HEPATOMEGALY; HUMAN; HUMAN TISSUE; IMMUNE DEFICIENCY; INFLAMMATION; JAUNDICE; LIVER BIOPSY; LIVER DYSFUNCTION; LIVER FIBROSIS; MALE; NONHODGKIN LYMPHOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT RESPONSE; VIREMIA; VIRUS LOAD;

EID: 77649194778     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181c2115a     Document Type: Article

References (10)

1. Alter MJ. Epidemiology of hepatitis C virus infection. World J Gastroen-terol. 2007;13:2436-2441.
2. Palumbo E. Treatment for chronic hepatitis C in children: a review. Am J Ther. In press.
3. Rosenthal P. Chronic hepatitis C viral infection in childhood: to treat or not to treat with interferon-that is the question. J Pediatr Gastroenterol Nutr. 1997;24:363-364.
4. Gigliotti AR, Fioredda F, Giacchino R. Hepatitis B and C infection in children undergoing chemotherapy or bone marrow transplantation. J Pe-diatr Hematol Oncol. 2003;25:184-192.
5. Bortolotti F, Verucchi G, Cammà C, et al. Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease. Gastroenterology. 2008;134:1900-1907.
6. Firpi RJ, Nelson DR. Management of viral hepatitis in hematologic malignancies. Blood Rev. 2008;22:117-126.
7. Gonzalez-Peralta RP, Kelly DA, Haber B, et al; for the International Pediatric Hepatitis C Therapy Group. Interferon Alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: efficacy, safety and pharmakokinetics. Hepatology. 2005;42:1010-1018.
8. Lackner H, Moser A, Deutsch J, et al. Interferon-a and ribavirin in treating children and young adults with chronic hepatitis C after malignancy. Pediatrics. 2000;106:E53.
9. Christensson B, Wiebe T, Akeson A, et al. Interferon-alpha and ribavirin treatment of hepatitis C in children with malignancy in remission. Clin Infect Dis. 2000;30:585-586.
10. Zuckerman E, Zuckerman T, Douer D, et al. Liver dysfynction in patients infected with hepatitis C virus undergoing chemotherapy for hematologic malignancies. Cancer. 1998;83:1224-1230.